Meta-analysis of 31 placebo-controlled RCTs (n=6437) of TNF and IL-17 inhibitors in axial spondyloarthritis: treatment effect on ASAS20 declined 5% per year, driven by rising placebo response; ASDAS-based treatment effects stayed stable.
Meta-analysisn = 6,437
Perrot et al. Evaluation of the placebo and treatment effect overtime in randomised clinical trials evaluating the efficacy of biologics in axial spondyloarthritis: systematic review and meta-analysis